Study Stopped
No patients enrolled during 2 years
Mannitol vs HS to Treat ICHT After Severe TBI : Comparison on PtiO2 and Microdialysis Values
Mannitol Versus Hypertonic Saline to Treat Intracranial Hypertension After Severe Traumatic Brain Injury : a Comparative Study on the Effects on PtiO2 and Microdialysis Values
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to determine whether hypertonic saline is as much effective as mannitol to treat intracranial hypertension after traumatic brain injury and has at least the same effects on PtiO2 and cerebral metabolism studied through microdialysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jul 2008
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 3, 2009
CompletedFirst Posted
Study publicly available on registry
December 9, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedAugust 8, 2012
August 1, 2012
3.9 years
December 3, 2009
August 7, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effects of HS versus mannitol on lactate/pyruvate ratio
20 min, 40 min, H1, H2, H3 and H4
Secondary Outcomes (8)
Metabolic profile evaluated thanks to measure of lactate/pyruvate ratio and cerebral glucose
20 min, 40 min, H1, H2, H3 and H4
Duration of PtiO2 > 15 mm Hg if PtiO2 was < 15 mm Hg before osmotherapy
20 min, 40 min, H1, H2, H3 et H4
Duration of ICP<20 mm Hg after osmotherapy
20 min, 40 min, H1, H2, H3 and H4
Interstitial osmolarity
20 min, 40 min and H1
Necessity of a third line therapy (hypothermia, craniectomy, propofol/barbiturate coma
Day after osmotherapy
- +3 more secondary outcomes
Study Arms (2)
Mannitol
ACTIVE COMPARATORHypertonic saline
EXPERIMENTALInterventions
2 mL/kg of 7.5% hypertonic saline associated to hydroxyethyl starch
Eligibility Criteria
You may qualify if:
- Severe Traumatic brain injury monitored with ICP, PtiO2 and cerebral microdialysis
- And ICP\> 20 mm Hg needing osmotherapy
- And approval of the next of kind
You may not qualify if:
- Bilateral fixed dilated pupils
- Contra-indication to multimodal neuromonitoring
- Previous CNS disease
- Contra-indication to HS (cardiac insufficiency,...)
- Natremia \> 155 mmol/L or osmolarity \> 320 mOsm/L
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HIA Sainte Anne
Toulon, 83130, France
Related Publications (3)
Vialet R, Albanese J, Thomachot L, Antonini F, Bourgouin A, Alliez B, Martin C. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med. 2003 Jun;31(6):1683-7. doi: 10.1097/01.CCM.0000063268.91710.DF.
PMID: 12794404BACKGROUNDSakowitz OW, Stover JF, Sarrafzadeh AS, Unterberg AW, Kiening KL. Effects of mannitol bolus administration on intracranial pressure, cerebral extracellular metabolites, and tissue oxygenation in severely head-injured patients. J Trauma. 2007 Feb;62(2):292-8. doi: 10.1097/01.ta.0000203560.03937.2d.
PMID: 17297315BACKGROUNDSoustiel JF, Vlodavsky E, Zaaroor M. Relative effects of mannitol and hypertonic saline on calpain activity, apoptosis and polymorphonuclear infiltration in traumatic focal brain injury. Brain Res. 2006 Jul 26;1101(1):136-44. doi: 10.1016/j.brainres.2006.05.045. Epub 2006 Jun 19.
PMID: 16787640BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Henry BORET, MD
Direction Centrale du Service de Santé des Armées
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Médecin en chef
Study Record Dates
First Submitted
December 3, 2009
First Posted
December 9, 2009
Study Start
July 1, 2008
Primary Completion
June 1, 2012
Study Completion
December 1, 2012
Last Updated
August 8, 2012
Record last verified: 2012-08